Goldman Sachs Alternatives Acquires Control of Italian Medtech Firm Numantec
Jul 27, 2026
Goldman Sachs Alternatives agreed to acquire Italian medtech firm Numantec from White Bridge Investment for approximately €700 million. Numantec manufactures healthcare products and drug-delivery devices across seven facilities in Europe and the US.
